Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Motion Exergaming Approach for Symptom Management: HNC
- Status
- RECRUITING
- Phase
- NA
Head and Neck cancERs International cOviD-19 collabOraTion
- Status
- UNKNOWN
- Phase
- N/A
Feasibility of Monitoring Patients During Radiotherapy Using Biometric Sensor Data: the OncoWatch Study 1.0
- Status
- COMPLETED
- Phase
- NA
Immunonutrition and Tolerance to Chemoradiotherapy in Patients With Head-neck Cancer
- Status
- RECRUITING
- Phase
- NA
Optical Coherence Tomography in Patients With Radiotherapy for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- N/A
Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Blinded Dry Mouth Spray Crossover Study
- Status
- COMPLETED
- Phase
- NA
Trial of BMX-001 or Placebo in Head and Neck Cancer Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)
- Status
- COMPLETED
- Phase
- N/A
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Real-time Detection of ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Prehabilitation and Recovery After Head and Neck Cancer Surgery
- Status
- UNKNOWN
- Phase
- NA
A Novel Skin Barrier Protectant for Acute Radiodermatitis
- Status
- WITHDRAWN
- Phase
- NA
Submandibular Gland Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue
- Status
- COMPLETED
- Phase
- N/A
COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
- Status
- AVAILABLE
- Phase
- N/A